Biotech Target N V - Jun 9, 2021 Form 3 Insider Report for MACROGENICS INC (MGNX)

Role: 10%+ Owner
Signature: /s/ Daniel Koller
Stock symbol: MGNX
Transactions as of: Jun 9, 2021
Transactions value $: $0
Form type: 3
Date filed: 6/11/2021, 05:21 PM
Previous filing: May 26, 2021
Next filing: Jun 17, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MGNX	Common Stock						6.03M	Jun 9, 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Macrogenics, Inc. held directly or indirectly by Biotech Target N.V. The Form 3 is jointly filed by BB Biotech AG and Biotech Target N.V.